← All Sponsors
SPONSOR

Luye Pharma Group Ltd.

Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2, Phase 3
Conditions studied: Tardive Dyskinesia (TD)Relapsed Small Cell Lung Cancer
NCT06731868 Phase 1, Phase 2
Recruiting

Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia

Tardive Dyskinesia (TD)
China View Trial →
NCT06128837 Phase 3
Recruiting

Study of LY01610 in Patients With Recurrent Small Cell Lung Cancer

Relapsed Small Cell Lung Cancer
China View Trial →